Login / Signup

Population-based BRCA1/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study.

Jane M TillerNicole E CousensRajneesh KaurSimone RowleyYi-An KoSakshi MahaleAgnes BankierBettina MeiserKristine Barlow-StewartLeslie BurnettChris JacobsPaul A JamesAlison TrainerSuzanne NeilIan G CampbellLesley AndrewsMartin Delatycki
Published in: Journal of medical genetics (2022)
Both B-JFM screening programmes are highly acceptable to Australian Jewish communities. The programme enabled identification of several individuals who were previously unaware they have a B-JFM, many of whom would have been ineligible for current criteria-based testing in Australia.
Keyphrases
  • breast cancer risk
  • healthcare
  • study protocol